Former President Trump claims tariff revenue can fund direct payments to Americans, bypassing Congress. Experts question the legality and economic feasibility of the proposal.
As states finalize legislation before the 2026 elections, a conservative-leaning watchdog group highlights vulnerabilities in the voting system, pushing for reforms to curb foreign influence and clarify citizenship requirements for voters.
In a fiery address to the U.S. Conference of Mayors, Minneapolis Mayor Jacob Frey called on local leaders nationwide to resist what he described as aggressive federal immigration enforcement, arguing such operations undermine public safety and constitutional rights.
Voyager Technologies has commenced a significant expansion of its defense manufacturing facility in Pueblo, Colorado, marking one of the region's largest military-industrial investments in recent years. The project aims to bolster domestic production for missile defense and munitions, integrating advanced automation and AI-driven logistics.
Shares of FMC Corporation have surged over 13% in the past month, sparking debate among investors. While the short-term bounce offers relief, it contrasts sharply with a punishing 70% decline over the past year. Analysts and investors are now weighing whether the current valuation gap represents a genuine opportunity or a reflection of deep-seated challenges.
Australia reaffirms its commitment to building resilient critical mineral supply chains and a strategic reserve, undeterred by the U.S. stepping back from plans to guarantee minimum prices for such projects.
A deep dive into the intrinsic value of Aurelius Technologies Berhad (KLSE:ATECH) using a Discounted Cash Flow model suggests a potential disconnect between its market price and fundamental valuation, raising questions for investors.
British pharmaceutical giant AstraZeneca has entered a strategic partnership with China's CSPC Pharmaceutical, committing over $1 billion upfront to co-develop next-generation obesity therapies, signaling intensified competition in the lucrative global weight-loss drug market.
Cardinal Health (CAH) stock has drawn renewed investor interest following robust financial results, with revenue topping $234 billion and net income near $1.6 billion. The healthcare distributor's shares have rallied over 66% in the past year, though its premium valuation compared to peers is sparking debate among analysts.
British American Tobacco's shares have soared over 138% in five years, but a deep dive into its valuation reveals a complex picture. While a discounted cash flow model suggests significant upside, its premium P/E ratio tells a more cautious tale, leaving investors to question if the rally has further to run.
